S4426-118

Introduced

To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.

118th Congress Introduced May 23, 2024

Legislative Progress

Introduced
Introduced Committee Passed
May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

May 23, 2024

Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, …

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology